Schedule 13G ownership disclosure

CLEARSIDE BIOMEDICAL INC

Security class unavailable · CUSIP: 185063104

Event date: 2017-04-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,649,264
Percent of class
10.4700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-17-000524
Form type
SC 13G/A
Filer
Clearside Biomedical, Inc.
CIK
CIK 1539029
Filed
May 09, 2017
Reporting period
Apr 28, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub